References    

 

 

 

Adams, M., M. J. Reginato, et al. (1997). "Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen- activated protein kinase site." J Biol Chem 272(8): 5128-32.

Adamson, D. J., D. Frew, et al. (2002). "Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling." Mol Pharmacol 61(1): 7-12.

Akiyama, T. E., S. Sakai, et al. (2002). "Conditional Disruption of the Peroxisome Proliferator-Activated Receptor gamma Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux." Mol Cell Biol 22(8): 2607-2619.

Altiok, S., M. Xu, et al. (1997). "PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA- binding activity via down-regulation of PP2A." Genes Dev 11(15): 1987-98.

Appel, B. and S. K. Fried (1992). "Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue." Am J Physiol 262(5 Pt 1): E695-9.

Asakawa, M., H. Takano, et al. (2002). "Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo." Circulation 105(10): 1240-6.

Auwerx, J. (2002). "Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?" Am J Physiol Gastrointest Liver Physiol 282(4): G581-5.

Baek, S. J., L. C. Wilson, et al. (2003). "Troglitazone, a Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) Ligand, Selectively Induces the Early Growth Response-1 Gene Independently of PPARgamma. A NOVEL MECHANISM FOR ITS ANTI-TUMORIGENIC ACTIVITY." J Biol Chem 278(8): 5845-53.

Barbier, O., L. Villeneuve, et al. (2003). "The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor alpha and gamma Target Gene." J Biol Chem 278(16): 13975-13983.

Barroso, I., M. Gurnell, et al. (1999). "Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension [see comments]." Nature 402(6764): 880-3.

Bar-Tana, J. (2001). "Peroxisome proliferator-activated receptor gamma (PPARgamma) activation and its consequences in humans." Toxicol Lett 120(1-3): 9-19.

Berger, J., M. D. Leibowitz, et al. (1999). "Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects." J Biol Chem 274(10): 6718-25.

Berger, J. and D. E. Moller (2002). "The mechanisms of action of ppars." Annu Rev Med 53: 409-35.

Berger, J., M. Tanen, et al. (2001). "Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity." J Biol Chem 276(16): 12629-35.

Braissant, O., F. Foufelle, et al. (1996). "Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat." Endocrinology 137(1): 354-66.

Braissant, O. and W. Wahli (1998). "Differential expression of peroxisome proliferator-activated receptor- alpha, -beta, and -gamma during rat embryonic development." Endocrinology 139(6): 2748-54.

Brown, P. J., D. A. Winegar, et al. (1999). "A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity." J Med Chem 42(19): 3785-8.

Brun, R. P. and B. M. Spiegelman (1997). "PPAR gamma and the molecular control of adipogenesis." J Endocrinol 155(2): 217-8.

Brun, R. P., P. Tontonoz, et al. (1996). "Differential activation of adipogenesis by multiple PPAR isoforms." Genes Dev 10(8): 974-84.

Burris, T. P., P. D. Pelton, et al. (1999). "A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation." Mol Endocrinol 13(3): 410-7.

Camp, H. S. and S. R. Tafuri (1997). "Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase." J Biol Chem 272(16): 10811-6.

Camp, H. S., S. R. Tafuri, et al. (1999). "c-Jun N-terminal kinase phosphorylates peroxisome proliferator- activated receptor-gamma1 and negatively regulates its transcriptional activity." Endocrinology 140(1): 392-7.

Castrillo, A., M. Mojena, et al. (2001). "Peroxisome proliferator-activated receptor-gamma -independent inhibition of macrophage activation by the non-thiazolidinedione agonist l-796,449. comparison with the effects of 15-deoxy-delta 12,14- prostaglandin j2." J Biol Chem 276(36): 34082-8.

Chen, S., B. A. Johnson, et al. (2000). "Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPARgamma) function." J Biol Chem 275(6): 3733-6.

Chevalier, S. and R. A. Roberts (1998). "Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review)." Oncol Rep 5(6): 1319-27.

Chevillotte, E., J. Rieusset, et al. (2001). "The Regulation of Uncoupling Protein-2 Gene Expression by omega -6 Polyunsaturated Fatty Acids in Human Skeletal Muscle Cells Involves Multiple Pathways, Including the Nuclear Receptor Peroxisome Proliferator-activated Receptor beta." J Biol Chem 276(14): 10853-10860.

Chinetti, G., J. C. Fruchart, et al. (2000). "Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation." Inflamm Res 49(10): 497-505.

Chinetti, G., S. Griglio, et al. (1998). "Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages." J Biol Chem 273(40): 25573-80.

Clark, R. B. (2002). "The role of PPARs in inflammation and immunity." J Leukoc Biol 71(3): 388-400.

Clarke, S. L., C. E. Robinson, et al. (1997). "CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter." Biochem Biophys Res Commun 240(1): 99-103.

Cunard, R., M. Ricote, et al. (2002). "Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors." J Immunol 168(6): 2795-802.

Cusin, I., J. Terrettaz, et al. (1990). "Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance." Endocrinology 127(6): 3246-8.

Dang, Z. C., V. Audinot, et al. (2003). "Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) as a Molecular Target for the Soy Phytoestrogen Genistein." J Biol Chem 278(2): 962-967.

Davies, S. S., A. V. Pontsler, et al. (2001). "Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists." J Biol Chem 276(19): 16015-23.

de Villiers, W. J. and E. J. Smart (1999). "Macrophage scavenger receptors and foam cell formation." J Leukoc Biol 66(5): 740-6.

De Vos, P., A. M. Lefebvre, et al. (1996). "Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma." J Clin Invest 98(4): 1004-9.

Dello Russo, C., V. Gavrilyuk, et al. (2003). "Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes." J Biol Chem 278(8): 5828-36.

Desvergne, B. and W. Wahli (1999). "Peroxisome proliferator-activated receptors: nuclear control of metabolism." Endocr Rev 20(5): 649-88.

DiRenzo, J., M. Soderstrom, et al. (1997). "Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors." Mol Cell Biol 17(4): 2166-76.

Dreyer, C., G. Krey, et al. (1992). "Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors." Cell 68(5): 879-87.

Escher, P., O. Braissant, et al. (2001). "Rat ppars: quantitative analysis in adult rat tissues and regulation in fasting and refeeding." Endocrinology 142(10): 4195-202.

Eubank, D. W., E. Duplus, et al. (2001). "Peroxisome Proliferator-activated Receptor gamma and Chicken Ovalbumin Upstream Promoter Transcription Factor II Negatively Regulate the Phosphoenolpyruvate Carboxykinase Promoter via a Common Element*." J Biol Chem 276(32): 30561-9.

Everett, L., A. Galli, et al. (2000). "The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease." Liver 20(3): 191-9.

Fahmi, H., J. P. Pelletier, et al. (2002). "Peroxisome proliferator-activated receptor gamma activators inhibit MMP- 1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1." Osteoarthritis Cartilage 10(2): 100-8.

Fajas, L., D. Auboeuf, et al. (1997). "The organization, promoter analysis, and expression of the human PPARgamma gene." J Biol Chem 272(30): 18779-89.

Fajas, L., K. Schoonjans, et al. (1999). "Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism." Mol Cell Biol 19(8): 5495-503.

Fauconnet, S., I. Lascombe, et al. (2002). "Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells." J Biol Chem 277(26): 23534-43.

Fehlberg, S., S. Trautwein, et al. (2002). "Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners." Biochem J 362(Pt 3): 573-8.

Feng, J., J. Han, et al. (2000). "Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma." J Lipid Res 41(5): 688-96.

Forman, B. M. (2002). "The Antidiabetic Agent LG100754 Sensitizes Cells to Low Concentrations of Peroxisome Proliferator-activated Receptor gamma Ligands." J Biol Chem 277(15): 12503-6.

Forman, B. M., J. Chen, et al. (1997). "Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta." Proc Natl Acad Sci U S A 94(9): 4312-7.

Forman, B. M., P. Tontonoz, et al. (1995). "15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma." Cell 83(5): 803-12.

Frohnert, B. I., T. Y. Hui, et al. (1999). "Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene." J Biol Chem 274(7): 3970-7.

Fu, M., J. Zhang, et al. (2002). "Early Growth Response Factor-1 Is a Critical Transcriptional Mediator of Peroxisome Proliferator-activated Receptor-gamma 1 Gene Expression in Human Aortic Smooth Muscle Cells." J Biol Chem 277(30): 26808-26814.

Fu, M., J. Zhang, et al. (2001). "Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3." J Biol Chem 276(49): 45888-94.

Gaillard, D., R. Negrel, et al. (1989). "Requirement and role of arachidonic acid in the differentiation of pre- adipose cells." Biochem J 257(2): 389-97.

Ge, K., M. Guermah, et al. (2002). "Transcription coactivator TRAP220 is required for PPARgamma2-stimulated adipogenesis." Nature 417(6888): 563-7.

Gearing, K. L., A. Crickmore, et al. (1994). "Structure of the mouse peroxisome proliferator activated receptor alpha gene." Biochem Biophys Res Commun 199(1): 255-63.

Gelman, L., G. Zhou, et al. (1999). "p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively." JBC 274(12): 7681-7688.

Gimble, J. M., G. M. Pighetti, et al. (1998). "Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands." Biochem Biophys Res Commun 253(3): 813-7.

Girard, J., D. Perdereau, et al. (1994). "Regulation of lipogenic enzyme gene expression by nutrients and hormones." Faseb J 8(1): 36-42.

Girnun, G. D., W. M. Smith, et al. (2002). "APC-dependent suppression of colon carcinogenesis by PPARgamma." Proc Natl Acad Sci U S A 99(21): 13771-6.

Gonzalez, F. J. and J. M. Peters (2001). The Peroxisome proliferator-activated receptors (PPAR):  Studies with null mice. Society of Toxicology, San Francisco, CA, Oxford University Press.

Gottlicher, M., E. Widmark, et al. (1992). "Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor." Proc Natl Acad Sci U S A 89(10): 4653-7.

Greene, M. E., B. Blumberg, et al. (1995). "Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping." Gene Expr 4(4-5): 281-99.

Grimaldi, P. A., L. Teboul, et al. (1997). "Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones." Prostaglandins Leukot Essent Fatty Acids 57(1): 71-5.

Guardiola-Diaz, H. M., S. Rehnmark, et al. (1999). "Rat peroxisome proliferator-activated receptors and brown adipose tissue function during cold acclimatization." J Biol Chem 274(33): 23368-77.

Gupta, R. A., J. A. Brockman, et al. (2001). "Target Genes of Peroxisome Proliferator-activated Receptor gamma in Colorectal Cancer Cells." J Biol Chem 276(32): 29681-29687.

Gupta, R. A., D. B. Polk, et al. (2001). "Activation of Peroxisome Proliferator-activated Receptor gamma Suppresses Nuclear Factor kappa B-mediated Apoptosis Induced by Helicobacter pylori in Gastric Epithelial Cells." J Biol Chem 276(33): 31059-66.

Gupta, R. A., P. Sarraf, et al. (2003). "Peroxisome Proliferator-activated Receptor {gamma}-mediated Differentiation: A MUTATION IN COLON CANCER CELLS REVEALS DIVERGENT AND CELL TYPE-SPECIFIC MECHANISMS." J Biol Chem 278(25): 22669-22677.

Gupta, R. A., P. Sarraf, et al. (2003). "Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms." J Biol Chem 278(25): 22669-77.

Han, J., D. P. Hajjar, et al. (2002). "Regulation of Peroxisome Proliferator-activated Receptor-gamma - mediated Gene Expression. A NEW MECHANISM OF ACTION FOR HIGH DENSITY LIPOPROTEIN." J Biol Chem 277(26): 23582-6.

Hansen, J. B., R. K. Petersen, et al. (1999). "Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation." J Biol Chem 274(4): 2386-93.

Hauser, S., G. Adelmant, et al. (2000). "Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation." J Biol Chem 275(24): 18527-33.

Heaney, A. P., M. Fernando, et al. (2003). "PPAR-gamma receptor ligands: novel therapy for pituitary adenomas." J Clin Invest 111(9): 1381-8.

Hegele, R. A., H. Cao, et al. (2002). "PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy." Diabetes 51(12): 3586-90.

Helledie, T., L. Grontved, et al. (2002). "The Gene Encoding the Acyl-CoA-binding Protein Is Activated by Peroxisome Proliferator-activated Receptor gamma through an Intronic Response Element Functionally Conserved between Humans and Rodents." J Biol Chem 277(30): 26821-26830.

Heneka, M. T., T. Klockgether, et al. (2000). "Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo." J Neurosci 20(18): 6862-7.

Houston, K. D., J. A. Copland, et al. (2003). "Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma." Cancer Res 63(6): 1221-7.

Hsi, L. C., L. Wilson, et al. (2001). "15-Lipoxygenase-1 Metabolites Down-regulate Peroxisome Proliferator- activated Receptor gamma via the MAPK Signaling Pathway." J Biol Chem 276(37): 34545-52.

Hsi, L. C., L. C. Wilson, et al. (2002). "Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma." J Biol Chem 277(43): 40549-56.

Hsu, M. H., C. N. Palmer, et al. (1995). "A single amino acid change in the mouse peroxisome proliferator- activated receptor alpha alters transcriptional responses to peroxisome proliferators." Mol Pharmacol 48(3): 559-67.

Hu, E., J. B. Kim, et al. (1996). "Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma." Science 274(5295): 2100-3.

Hu, E., P. Tontonoz, et al. (1995). "Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha." Proc Natl Acad Sci U S A 92(21): 9856-60.

Hunter, J. G., M. F. van Delft, et al. (2001). "Peroxisome Proliferator-activated Receptor gamma Ligands Differentially Modulate Muscle Cell Differentiation and MyoD Gene Expression via Peroxisome Proliferator-activated Receptor gamma -dependent and - independent Pathways." J Biol Chem 276(41): 38297-306.

Iida, K. T., Y. Kawakami, et al. (2002). "PPARgamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages." FEBS Lett 520(1-3): 177-81.

Ip, C., M. M. Ip, et al. (2000). "Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland." Cancer Epidemiol Biomarkers Prev 9(7): 689-96.

Jiang, C., A. T. Ting, et al. (1998). "PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines." Nature 391(6662): 82-6.

Jiang, J. G., C. Johnson, et al. (2001). "Peroxisome Proliferator-activated Receptor gamma -mediated Transcriptional Up-regulation of the Hepatocyte Growth Factor Gene Promoter via a Novel Composite cis-Acting Element." J Biol Chem 276(27): 25049-56.

Kalkhoven, E., J. E. Valentine, et al. (1998). "Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor." Embo J 17(1): 232-43.

Kallen, C. B. and M. A. Lazar (1996). "Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes." Proc Natl Acad Sci U S A 93(12): 5793-6.

Kamei, Y., L. Xu, et al. (1996). "A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors." Cell 85(3): 403-14.

Kao, W. H., J. Coresh, et al. (2003). "Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study." Diabetes 52(6): 1568-72.

Kawai, T., H. Hirose, et al. (2002). "Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma." Diabetes Res Clin Pract 56(2): 83-92.

Kersten, S. (2001). "Mechanisms of nutritional and hormonal regulation of lipogenesis." EMBO Rep 2(4): 282-6.

Kersten, S., B. Desvergne, et al. (2000). "Roles of PPARs in health and disease." Nature 405(6785): 421-4.

Kim, J. B. and B. M. Spiegelman (1996). "ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism." Genes Dev 10(9): 1096-107.

Kim, J. B., H. M. Wright, et al. (1998). "ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand." Proc Natl Acad Sci U S A 95(8): 4333-7.

Kim, Y. S., C. Y. Han, et al. (2001). "The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-kappa b in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7." J Biol Chem 276(36): 33736-40.

Kishida, K., I. Shimomura, et al. (2001). "Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma." J Biol Chem 276(51): 48572-9.

Kliewer, S. A., B. M. Forman, et al. (1994). "Differential expression and activation of a family of murine peroxisome proliferator-activated receptors." Proc Natl Acad Sci U S A 91(15): 7355-9.

Kliewer, S. A., J. M. Lenhard, et al. (1995). "A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation." Cell 83(5): 813-9.

Kliewer, S. A., S. S. Sundseth, et al. (1997). "Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma." Proc Natl Acad Sci U S A 94(9): 4318-23.

Kodera, Y., K. Takeyama, et al. (2000). "Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators." J Biol Chem 275(43): 33201-4.

Krey, G., O. Braissant, et al. (1997). "Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator- dependent receptor ligand assay." Mol Endocrinol 11(6): 779-91.

Krey, G., H. Keller, et al. (1993). "Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids." J Steroid Biochem Mol Biol 47(1-6): 65-73.

Lambe, K. G. and J. D. Tugwood (1996). "A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs." Eur J Biochem 239(1): 1-7.

Lavinsky, R. M., K. Jepsen, et al. (1998). "Diverse signaling pathways modulate nuclear receptor recruitment of N- CoR and SMRT complexes." Proc Natl Acad Sci U S A 95(6): 2920-5.

Lazar, M. A. (2002). "Becoming fat." Genes Dev 16(1): 1-5.

Lee, G., F. Elwood, et al. (2002). "T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor gamma, Functions as an Antagonist of Biochemical and Cellular Activities." J Biol Chem 277(22): 19649-57.

Leesnitzer, L. M., D. J. Parks, et al. (2002). "Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662." Biochemistry 41(21): 6640-50.

Lefebvre, A. M., I. Chen, et al. (1998). "Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice." Nat Med 4(9): 1053-7.

Lehmann, J. M., J. M. Lenhard, et al. (1997). "Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs." J Biol Chem 272(6): 3406-10.

Lehmann, J. M., L. B. Moore, et al. (1995). "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)." J Biol Chem 270(22): 12953-6.

Lennon, A. M., M. Ramauge, et al. (2002). "MAP Kinase Cascades Are Activated in Astrocytes and Preadipocytes by 15- Deoxy-Delta 12-14-prostaglandin J2 and the Thiazolidinedione Ciglitazone through Peroxisome Proliferator Activator Receptor gamma - independent Mechanisms Involving Reactive Oxygenated Species." J Biol Chem 277(33): 29681-29685.

Li, H., P. J. Gomes, et al. (1997). "RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2." Proc Natl Acad Sci U S A 94(16): 8479-84.

Li, L., J. Tao, et al. (2001). "15-Deoxy-delta 12,14-prostaglandin j2 induces apoptosis of human hepatic myofibroblasts. a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors." J Biol Chem 276(41): 38152-8.

Li, M., G. Pascual, et al. (2000). "Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene." Mol Cell Biol 20(13): 4699-707.

Lowell, B. B. (1999). "PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function." Cell 99(3): 239-42.

Ma, H., H. W. Sprecher, et al. (1998). "Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue." J Biol Chem 273(46): 30131-8.

MacDougald, O. A. and M. D. Lane (1995). "Transcriptional regulation of gene expression during adipocyte differentiation." Annu Rev Biochem 64: 345-73.

Man, M. Z., T. Y. Hui, et al. (1996). "Regulation of the murine adipocyte fatty acid transporter gene by insulin." Mol Endocrinol 10(8): 1021-8.

Mansen, A., H. Guardiola-Diaz, et al. (1996). "Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa." Biochem Biophys Res Commun 222(3): 844-51.

Martin, G., K. Schoonjans, et al. (1997). "Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators." J Biol Chem 272(45): 28210-7.

Masamune, A., K. Kikuta, et al. (2002). "Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells." J Biol Chem 277(1): 141-7.

Matsusue, K., M. Haluzik, et al. (2003). "Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes." J Clin Invest 111(5): 737-47.

McInerney, E. M., D. W. Rose, et al. (1998). "Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation." Genes Dev 12(21): 3357-68.

McIntyre, T. M., A. V. Pontsler, et al. (2003). "Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist." Proc Natl Acad Sci U S A 100(1): 131-6.

Medvedev, A. V., S. K. Snedden, et al. (2001). "Transcriptional Regulation of the Mouse Uncoupling Protein-2 Gene. DOUBLE E-BOX MOTIF IS REQUIRED FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-gamma -DEPENDENT ACTIVATION." J Biol Chem 276(14): 10817-10823.

Michalik, L., B. Desvergne, et al. (2002). "PPAR expression and function during vertebrate development." Int J Dev Biol 46(1): 105-14.

Moore, K. J., M. L. Fitzgerald, et al. (2001). "Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?" Curr Opin Lipidol 12(5): 519-27.

Motojima, K., P. Passilly, et al. (1998). "Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner." J Biol Chem 273(27): 16710-4.

Moya-Camarena, S. Y., J. P. Vanden Heuvel, et al. (1999). "Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha." J Lipid Res 40(8): 1426-33.

Mueller, E., S. Drori, et al. (2002). "Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms." J Biol Chem 277(44): 41925-30.

Mueller, E., P. Sarraf, et al. (1998). "Terminal differentiation of human breast cancer through PPAR gamma." Mol Cell 1(3): 465-70.

Nagy, L., P. Tontonoz, et al. (1998). "Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma." Cell 93(2): 229-40.

Nawa, T., M. T. Nawa, et al. (2000). "Repression of TNF-alpha-induced E-selectin expression by PPAR activators: involvement of transcriptional repressor LRF-1/ATF3." Biochem Biophys Res Commun 275(2): 406-11.

Negrel, R., D. Gaillard, et al. (1989). "Prostacyclin as a potent effector of adipose-cell differentiation." Biochem J 257(2): 399-405.

Nolte, R. T., G. B. Wisely, et al. (1998). "Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-gamma." Nature 395(6698): 137-43.

Oberfield, J. L., J. L. Collins, et al. (1999). "A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation." Proc Natl Acad Sci U S A 96(11): 6102-6.

O'Brien, R. M. and D. K. Granner (1996). "Regulation of gene expression by insulin." Physiol Rev 76(4): 1109-61.

Okuno, M., E. Arimoto, et al. (2002). "Isolation of up- or down-regulated genes in PPARgamma-expressing NIH- 3T3 cells during differentiation into adipocytes." FEBS Lett 519(1-3): 108-12.

Oliver, W. R., Jr., J. L. Shenk, et al. (2001). "A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport." Proc Natl Acad Sci U S A 98(9): 5306-5311.

Oram, J. F. and R. M. Lawn (2001). "ABCA1. The gatekeeper for eliminating excess tissue cholesterol." J Lipid Res 42(8): 1173-9.

Panigrahy, D., S. Singer, et al. (2002). "PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis." J Clin Invest 110(7): 923-32.

Patane, G., M. Anello, et al. (2002). "Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor- gamma Inhibition." Diabetes 51(9): 2749-56.

Pawliczak, R., C. Han, et al. (2002). "85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells." J Biol Chem 277(36): 33153-63.

Pearson, S. L., M. A. Cawthorne, et al. (1996). "The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats." Biochem Biophys Res Commun 229(3): 752-7.

Pontsler, A. V., A. St Hilaire, et al. (2002). "Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome Proliferator Activated Receptor gamma and Oxidized Alkyl Phospholipids from Oxidized Low Density Lipoprotein." J Biol Chem 277(15): 13029-36.

Porras, A., A. Valladares, et al. (2002). "Differential role of PPARgamma in the regulation of UCP-1 and adipogenesis by TNF-alpha in brown adipocytes." FEBS Lett 520(1-3): 58-62.

Poulsen, P., G. Andersen, et al. (2003). "Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?" Diabetes 52(1): 194-8.

qOlswang, Y., H. Cohen, et al. (2002). "A mutation in the peroxisome proliferator-activated receptor gamma - binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice." Proc Natl Acad Sci U S A 99(2): 625-630.

Reginato, M. J., S. L. Krakow, et al. (1998). "Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma." J Biol Chem 273(4): 1855-8.

Ren, D., T. N. Collingwood, et al. (2002). "PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis." Genes Dev 16(1): 27-32.

Ribon, V., J. H. Johnson, et al. (1998). "Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene." Proc Natl Acad Sci U S A 95(25): 14751-6.

Ricote, M., J. Huang, et al. (1998). "Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein." Proc Natl Acad Sci U S A 95(13): 7614-9.

Ricote, M., J. T. Huang, et al. (1999). "The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function." J Leukoc Biol 66(5): 733-9.

Ricote, M., A. C. Li, et al. (1998). "The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation." Nature 391(6662): 79-82.

Rieusset, J., F. Andreelili, et al. (1999). "Insulin acutely regulates the expression of the peroxisome proliferator activated receptor-gamma in human adipocytes." Diabetes 48: 699-705.

Rosen, E. D., C. H. Hsu, et al. (2002). "C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway." Genes Dev 16(1): 22-6.

Rosen, E. D. and B. M. Spiegelman (2001). "Ppargamma : a nuclear regulator of metabolism, differentiation, and cell growth." J Biol Chem 276(41): 37731-4.

Rubin, G. L., Y. Zhao, et al. (2000). "Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy." Cancer Res 60(6): 1604-8.

Saez, E., P. Tontonoz, et al. (1998). "Activators of the nuclear receptor PPARgamma enhance colon polyp formation." Nat Med 4(9): 1058-61.

Saladin, R., L. Fajas, et al. (1999). "Differential Regulation of Peroxisome Proliferator Activated Receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis." Cell Growth & Differentiation 10: 43-48.

Saltiel, A. R. and J. M. Olefsky (1996). "Thiazolidinediones in the treatment of insulin resistance and type II diabetes." Diabetes 45(12): 1661-9.

Sarraf, P., E. Mueller, et al. (1998). "Differentiation and reversal of malignant changes in colon cancer through PPARgamma [see comments]." Nat Med 4(9): 1046-52.

Schaffer, J. E. and H. F. Lodish (1994). "Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein [see comments]." Cell 79(3): 427-36.

Schinner, S., C. Dellas, et al. (2002). "Repression of Glucagon Gene Transcription by Peroxisome Proliferator- activated Receptor gamma through Inhibition of Pax6 Transcriptional Activity." J Biol Chem 277(3): 1941-8.

Schoonjans, K., J. Peinado-Onsurbe, et al. (1996). "PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene." Embo J 15(19): 5336-48.

Schoonjans, K., B. Staels, et al. (1993). "Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation." Eur J Biochem 216(2): 615-22.

Schoonjans, K., M. Watanabe, et al. (1995). "Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter." J Biol Chem 270(33): 19269-76.

Schulman, I. G., G. Shao, et al. (1998). "Transactivation by retinoid X receptor-peroxisome proliferator- activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function." Mol Cell Biol 18(6): 3483-94.

Segawa, Y., R. Yoshimura, et al. (2002). "Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer." Prostate 51(2): 108-16.

Setoguchi, K., Y. Misaki, et al. (2001). "Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis." J Clin Invest 108(11): 1667-75.

Shalev, A., C. A. Siegrist-Kaiser, et al. (1996). "The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin." Endocrinology 137(10): 4499-4502.

Shao, D., S. M. Rangwala, et al. (1998). "Interdomain communication regulating ligand binding by PPAR-gamma." Nature 396(6709): 377-80.

Shao, J., H. Sheng, et al. (2002). "Peroxisome Proliferator-activated Receptors Modulate K-Ras-mediated Transformation of Intestinal Epithelial Cells." Cancer Res 62(11): 3282-8.

Shappell, S. B., R. A. Gupta, et al. (2001). "15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator- activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells." Cancer Res 61(2): 497-503.

Shibuya, A., K. Wada, et al. (2002). "Nitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264." FEBS Lett 525(1-3): 43.

Souza, S. C., M. T. Yamamoto, et al. (1998). "BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones." Diabetes 47(4): 691-5.

Spiegelman, B. M. (1998). "PPAR-gamma: adipogenic regulator and thiazolidinedione receptor." Diabetes 47(4): 507-14.

Straus, D. S., G. Pascual, et al. (2000). "15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF- kappa B signaling pathway." Proc Natl Acad Sci U S A 97(9): 4844-9.

Sueyoshi, S., T. Yamada, et al. (2001). "Expression of peroxisome proliferator-activated receptor subtypes in human atherosclerosis." Ann N Y Acad Sci 947: 429-32.

Sugawara, A., A. Uruno, et al. (2002). "Transcription Suppression of Thromboxane Receptor Gene by Peroxisome Proliferator-activated Receptor-gamma via an Interaction with Sp1 in Vascular Smooth Muscle Cells." J Biol Chem 277(12): 9676-83.

Sugiyama, H., T. Nonaka, et al. (2000). "Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation." Eur J Immunol 30(12): 3363-70.

Tai, T. A., C. Jennermann, et al. (1996). "Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation." J Biol Chem 271(47): 29909-14.

Takahashi, N., T. Kawada, et al. (2002). "Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma." J Biol Chem 277(19): 16906-12.

Takano, H. and I. Komuro (2002). "Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease." J Diabetes Complications 16(1): 108-14.

Tan, N. S., N. S. Shaw, et al. (2002). "Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription." Mol Cell Biol 22(14): 5114-27.

Tanaka, T., N. Yoshida, et al. (1997). "Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene." Embo J 16(24): 7432-43.

Teruel, T., J. C. Clapham, et al. (1999). "PPARalpha activation by Wy 14643 induces transactivation of the rat UCP- 1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes [In Process Citation]." Biochem Biophys Res Commun 264(2): 311-5.

Thieringer, R., J. E. Fenyk-Melody, et al. (2000). "Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo." J Immunol 164(2): 1046-54.

Thuillier, P., R. Baillie, et al. (1998). "Cytosolic and nuclear distribution of PPARgamma2 in differentiating 3T3- L1 preadipocytes." J Lipid Res 39(12): 2329-38.

Tontonoz, P., R. A. Graves, et al. (1994). "Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha." Nucleic Acids Res 22(25): 5628-34.

Tontonoz, P., E. Hu, et al. (1995). "PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene." Mol Cell Biol 15(1): 351-7.

Tontonoz, P., E. Hu, et al. (1994). "mPpar gamma 2: tissue-specific regulator of an adipocyte enhancer." Genes Dev 8(10): 1224-34.

Tontonoz, P., E. Hu, et al. (1994). "Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid- activated transcription factor [published erratum appears in Cell 1995 Mar 24;80(6):following 957]." Cell 79(7): 1147-56.

Tontonoz, P., E. Hu, et al. (1995). "Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma." Curr Opin Genet Dev 5(5): 571-6.

Tontonoz, P., L. Nagy, et al. (1998). "PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL." Cell 93(2): 241-52.

Tontonoz, P., S. Singer, et al. (1997). "Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor." Proc Natl Acad Sci U S A 94(1): 237-41.

Torchia, J., D. W. Rose, et al. (1997). "The transcriptional co-activator p/CIP binds CBP and mediates nuclear- receptor function [see comments]." Nature 387(6634): 677-84.

Tordjman, K., C. Bernal-Mizrachi, et al. (2001). "PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice." J Clin Invest 107(8): 1025-34.

Toyota, M., Y. Miyazaki, et al. (2002). "Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1." Life Sci 70(13): 1565-75.

Uppenberg, J., C. Svensson, et al. (1998). "Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma." J Biol Chem 273(47): 31108-12.

Valmaseda, A., M. C. Carmona, et al. (1999). "Opposite regulation of PPAR-alpha and -gamma gene expression by both their ligands and retinoic acid in brown adipocytes." Mol Cell Endocrinol 154(1-2): 101-9.

Vanden Heuvel, J. P. and J. M. Peters (2000). "Biology of the PPAR family of receptors."? ?

Vidal, H., D. Auboeuf, et al. (1996). "The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue." J Clin Invest 98(2): 251-5.

Vidal-Puig, A., M. Jimenez-Linan, et al. (1996). "Regulation of PPAR gamma gene expression by nutrition and obesity in rodents." J Clin Invest 97(11): 2553-61.

Vidal-Puig, A. J., R. V. Considine, et al. (1997). "Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids." J Clin Invest 99(10): 2416-22.

Voegel, J. J., M. J. Heine, et al. (1998). "The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways." Embo J 17(2): 507-19.

Wahl, H. G., C. Kausch, et al. (2002). "Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures." Diabetes 51(4): 1060-5.

Wakino, S., U. Kintscher, et al. (2000). "Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells." J Biol Chem 275(29): 22435-41.

Wang, C., M. Fu, et al. (2001). "Inhibition of Cellular Proliferation through IkappaB Kinase-Independent and Peroxisome Proliferator-Activated Receptor gamma-Dependent Repression of Cyclin D1." Mol Cell Biol 21(9): 3057-70.

Wang, N., L. Verna, et al. (2002). "Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells." J Biol Chem 277(37): 34176-81.

Wang, Y. L., K. A. Frauwirth, et al. (2002). "Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival." J Biol Chem 277(35): 31781-8.

Wayman, N. S., Y. Hattori, et al. (2002). "Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size." Faseb J 16(9): 1027-40.

Welch, J. S., M. Ricote, et al. (2003). "PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages." Proc Natl Acad Sci U S A 100(11): 6712-7.

Werman, A., A. Hollenberg, et al. (1997). "Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin." J Biol Chem 272(32): 20230-5.

Westin, S., R. Korokawa, et al. (1998). "Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators." Nature 395: 199-202.

Willson, T. M., J. E. Cobb, et al. (1996). "The structure-activity relationship between peroxisome proliferator- activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones." J Med Chem 39(3): 665-8.

Wu, Z., N. L. Bucher, et al. (1996). "Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids." Mol Cell Biol 16(8): 4128-36.

Xu, Y., L. Lu, et al. (2003). "Deleterious Effects of Acute Treatment With a Peroxisome Proliferator-Activated Receptor-gamma Activator in Myocardial Ischemia and Reperfusion in Pigs." Diabetes 52(5): 1187-94.

Yamakawa-Karakida, N., K. Sugita, et al. (2002). "Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity." Cell Death Differ 9(5): 513-26.

Yamauchi, T., J. Kamon, et al. (2001). "The mechanisms by which both heterozygous peroxisome proliferator- activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance." J Biol Chem 276(44): 41245-54.

Yamauchi, T., H. Waki, et al. (2001). "Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes." J Clin Invest 108(7): 1001-1013.

Yang, W. L. and H. Frucht (2001). "Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells." Carcinogenesis 22(9): 1379-83.

Yao, T. P., G. Ku, et al. (1996). "The nuclear hormone receptor coactivator SRC-1 is a specific target of p300." Proc Natl Acad Sci U S A 93(20): 10626-31.

Yu, K., W. Bayona, et al. (1995). "Differential activation of peroxisome proliferator-activated receptors by eicosanoids." J Biol Chem 270(41): 23975-83.

Yu, S., K. Matsusue, et al. (2003). "Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor gamma 1 (PPARgamma 1) Overexpression." J Biol Chem 278(1): 498-505.

Yu, Y., P. H. Correll, et al. (2002). "Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARgamma-dependent mechanism." Biochim Biophys Acta 1581(3): 89-99.

Yuan, C. X., M. Ito, et al. (1998). "The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion [published erratum appears in Proc Natl Acad Sci U S A 1998 Nov 24;95(24):14584]." Proc Natl Acad Sci U S A 95(14): 7939-44.

Zamir, I., J. Zhang, et al. (1997). "Stoichiometric and steric principles governing repression by nuclear hormone receptors." Genes Dev 11(7): 835-46.

Zhang, B., J. Berger, et al. (1996). "Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha." Mol Endocrinol 10(11): 1457-66.

Zhang, B., J. Berger, et al. (1996). "Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma." J Biol Chem 271(50): 31771-4.

Zhang, B., M. P. Graziano, et al. (1996). "Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice." J Biol Chem 271(16): 9455-9.

Zhang, Y., R. Proenca, et al. (1994). "Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments]." Nature 372(6505): 425-32.

Zhou, G., R. Cummings, et al. (1998). "Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer." Mol Endocrinol 12(10): 1594-604.

Zhu, Y., K. Alvares, et al. (1993). "Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver." J Biol Chem 268(36): 26817-20.

Zhu, Y., C. Qi, et al. (1996). "Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma." Gene Expr 6(3): 185-95.

Zhu, Y., C. Qi, et al. (1997). "Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor." J Biol Chem 272(41): 25500-6.

Zhu, Y., C. Qi, et al. (1995). "Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms." Proc Natl Acad Sci U S A 92(17): 7921-5.